Used for the quantitative measurement of Gaucher disease-related enzyme activity in biological samples, this ELISA kit enables researchers to assess glucocerebrosidase (GAA) enzyme levels in cell lysates, tissue homogenates, and serum. It is widely applied in clinical research and drug development for monitoring disease progression and evaluating therapeutic efficacy in lysosomal storage disorders. The kit provides a reliable, sensitive, and high-throughput method for enzyme activity analysis, supporting studies in metabolic disease diagnostics and enzyme replacement therapy.